Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunological Response following heterologous prime-boost primary series and booster COVID-19 vaccination
TCTR20210720007Phase 2Enrolling by invitation
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jul 2021
- Countries
- 1
01
Overview
Phase 2 trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jul 2021; status: enrolling by invitation.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210720007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210720007.